Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $690.71 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $119.57 | 9 | $0 (2020) |
| ABBVIE INC. | $113.86 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $89.03 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $54.41 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46.12 | 3 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $43.77 | 6 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $32.08 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $28.11 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $25.69 | 2 | $0 (2022) |
| ACUMED LLC | $21.64 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.34 | 1 | ABBVIE INC. ($22.34) |
| 2023 | $248.67 | 14 | ABBVIE INC. ($66.70) |
| 2022 | $124.41 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($31.52) |
| 2020 | $40.48 | 3 | Novo Nordisk Inc ($27.55) |
| 2019 | $73.84 | 6 | Novo Nordisk Inc ($25.01) |
| 2018 | $89.22 | 9 | Sunovion Pharmaceuticals Inc. ($30.84) |
| 2017 | $91.75 | 7 | Novo Nordisk Inc ($40.25) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | ACUMED LLC | INnate Implant (Device), InFrame Implant | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Screw & Pin | ||||||
| 10/03/2023 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 06/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardio-renal | ||||||
| 05/31/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardio-renal | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Cardio-renal | ||||||
| 04/11/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: ETONOGESTREL | ||||||
| 02/08/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: ETONOGESTREL | ||||||
| 01/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardio-renal | ||||||
| 01/11/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Cardio-renal | ||||||
| 11/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardio-renal | ||||||
| 10/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Central Nervous System | ||||||
| 08/31/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PROQUAD, VAXELIS | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: VACCINE | ||||||
| 06/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: DIABETES | ||||||
| 09/23/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Diabetes | ||||||
| 08/18/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Diabetes | ||||||
About Dr. Michael Mcnamara, D.O
Dr. Michael Mcnamara, D.O is a General Practice healthcare provider based in Lewiston, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801860440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Mcnamara, D.O has received a total of $690.71 in payments from pharmaceutical and medical device companies, with $22.34 received in 2024. These payments were reported across 48 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($690.71).
Practice Information
- Specialty General Practice
- Location Lewiston, MI
- Active Since 02/13/2006
- Last Updated 05/07/2014
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1801860440
Products in Payments
- Kerendia (Drug) $89.03
- VRAYLAR (Drug) $60.88
- Victoza (Drug) $56.42
- FARXIGA (Drug) $54.41
- Ozempic (Drug) $52.56
- QULIPTA (Drug) $34.90
- TRADJENTA (Drug) $33.79
- SPRAVATO (Drug) $32.08
- UBRELVY (Drug) $31.80
- LONHALA MAGNAIR (Drug) $31.71
- INnate Implant (Device) $21.64
- CRYSVITA (Drug) $21.48
- AUSTEDO (Drug) $16.08
- Prolia (Biological) $14.25
- GARDASIL 9 (Biological) $13.62
- CAPLYTA (Drug) $13.09
- JARDIANCE (Drug) $12.33
- JANUVIA (Drug) $12.07
- UTIBRON (Drug) $12.06
- AJOVY (Drug) $12.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Lewiston
Dr. Erin Leavitt
General Practice — Payments: $5,189
Dr. Benjamin Waites, Dmd, DMD
General Practice — Payments: $1,267
Dr. Peter Drews, Dds, DDS
General Practice — Payments: $899.32
Dr. Sang Joon Lee, Dmd, DMD
General Practice — Payments: $618.07
John Mladucky, Pa-C, PA-C
General Practice — Payments: $531.20
Kevin Connelly, D.m.d, D.M.D
General Practice — Payments: $457.18